Mereo BioPharma Group plc (MREO)
MREO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3200
+1.52% on the day
Market cap
$51.1M
Micro cap
Revenue · 2025
$500K
Prior year not contiguous
Net income · 2025
$41.9M
8375.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | MREO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United Kingdom |
| IPO year | Not reported by the screener |
| SEC CIK | 0001719714 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | X0 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $500K |
| Net income | $41.9M |
| Operating income | -$40.1M |
| Net margin | 8375.6% |
| Operating margin | -8021.4% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $41.0M |
| Total assets | $45.9M |
| P/E (computed) | 1.2× |
| P/S (computed) | 102.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-12-04 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-19 |
| Latest proxy | DEF 14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 438 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HYPD | Hyperion DeFi Inc. | $3.36 | -3.17% | $51.9M |
| IBIO | iBio Inc. | $0.7818 | -13.44% | $50.3M |
| ATHE | Alterity Therapeutics Limited | $2.85 | -2.73% | $51.9M |
| RNXT | RenovoRx Inc. | $1.15 | -8.00% | $51.9M |
| CLNN | Clene Inc. | $3.39 | -7.88% | $48.2M |
| HOWL | Werewolf Therapeutics Inc. | $0.9911 | +0.95% | $48.2M |
| ALDX | Aldeyra Therapeutics Inc. | $0.8998 | -0.66% | $54.3M |
| ELTX | Elicio Therapeutics Inc. | $1.77 | -5.85% | $48.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier